Haemorrhoids (piles): treatment, bleeding safety and supplement evidence

Haemorrhoids, also spelled hemorrhoids and called piles, are anal vascular tissues that can become enlarged or symptomatic. Confidence: high for examination of rectal bleeding, bowel-habit care and selecting treatment by symptoms and anatomy; insufficient for an independent herbal or flavonoid product recommendation. Mild discomfort often improves with conservative care. Bleeding, severe pain, persistent symptoms or an unusual lump need assessment so another condition is not missed.

Table of contents

• Evidence summary
• What haemorrhoids are
• How it works
• The evidence-based treatments
• Supplement and lifestyle evidence
• What works and what does not
• Risks and side effects
• Important interactions
• Who needs special assessment
• Clinician-led treatment and use
• Animal and in-vitro evidence
• Funding and source roles
• Frequently asked questions
• Sources and funding notes

Evidence summary

Clinical guidance, human outcome research and funding independence answer different questions. The guidance below explains care; it does not independently reproduce the trials behind a medicine or supplement.

What haemorrhoids are

Haemorrhoidal tissue is part of normal anatomy. Disease refers to tissue that becomes enlarged or causes troublesome bleeding, prolapse, discomfort or hygiene problems. Having this tissue does not by itself mean that a procedure is necessary. ASCRS anatomy and symptom context.

Internal haemorrhoids are located within the anal canal; external haemorrhoids lie around the anus under sensitive skin. Both can coexist. Internal disease commonly causes bright red bleeding or prolapse, whereas a clot in an external haemorrhoid can cause a suddenly painful lump. NIDDK symptom patterns.

Prolapse grades describe whether internal tissue stays inside, comes out and returns by itself, requires reduction or cannot be returned. These grades help describe anatomy, but the need for treatment also depends on symptoms and examination. A photograph or self-assigned grade is not a complete assessment. ASCRS prolapse classification.

How it works

Straining, prolonged toilet sitting, constipation, diarrhoea, pregnancy and weakening support with age can contribute to symptomatic disease. The exact cause is not always clear; not every episode can be traced to a single meal or activity. NIDDK contributing factors.

A haemorrhoid can bleed when the tissue is irritated, while prolapse can interfere with cleaning and cause mucus or irritation. A thrombosed external haemorrhoid contains a local clot; a clinician needs to distinguish it from other painful anal swellings. NIDDK anatomy and complications.

A soft skin tag can remain after an external clot resolves. That is different from ongoing thrombosis or a new painful mass. Tell the clinician whether the lump is new, painful, changing or associated with bleeding; these details are more useful than assuming every lump is a pile. NIDDK examination findings.

Pain during or after stool passage can also come from a fissure, and bleeding can come from other bowel disease. Treating presumed piles repeatedly without confirming the cause can delay appropriate care. NIDDK alternative causes.

The evidence-based treatments

Assessment begins with symptoms, duration, bowel habits, prior treatments, medicines and relevant personal/family history. Examination may include inspection, a gloved-finger rectal examination and anoscopy to look within the anal canal. NIDDK diagnostic approach.

A clinician may arrange further bowel investigation when the bleeding source is uncertain or other features warrant it. Seeing a haemorrhoid does not prove it explains all bleeding. Persistent bleeding, unexplained weight loss, altered bowel habits or unusual tiredness should be discussed explicitly. NHS rectal-bleeding assessment.

Conservative care usually starts with addressing difficult stool passage, avoiding straining and limiting unnecessary toilet sitting. A pharmacist or clinician may recommend a suitable fibre preparation or laxative when constipation contributes. The plan should also consider frequent loose stools. NIDDK initial treatment.

A selected internal haemorrhoid may be treated with rubber-band ligation, sclerotherapy or a coagulation technique. These are clinical procedures; banding must never be attempted at home. They do not apply in the same way to a painful external lump. NIDDK office procedures.

Surgery can be considered for larger external disease, combined disease or persistent prolapse that has not responded adequately. The discussion should cover the expected benefit, recovery, recurrence and procedure-specific complications. Do not choose a technique solely from an advertisement promising painless permanent treatment.

Selected thrombosed external haemorrhoids may need procedural assessment, especially with severe pain. There is no universal home rule that every clot must be removed or that a certain number of hours determines eligibility. Examination and the course of symptoms guide the decision. ASCRS thrombosis context.

Supplement and lifestyle evidence

Fibre-rich food can support easier stool passage. Fruits, vegetables, pulses and whole grains offer different ways to increase fibre; a dietitian can adapt the plan to appetite and food tolerance. Adequate fluid should be individualized to health and activity rather than copied from a fixed online target. NIDDK nutrition context.

A bulk-forming fibre preparation is an option within bowel-habit care, not a guarantee that prolapse disappears. Before using ispaghula, seek advice about swallowing difficulty, suspected obstruction, significant pain with vomiting or an unusual change in bowel habit. NHS fibre suitability.

Plant-derived phlebotonics, including flavonoids, appear in the ASCRS guideline’s research discussion. The underlying studies use different products and this article has not cleared every trial’s funding, author interests and product provision. No commercial flavonoid preparation receives an independent efficacy verdict here. ASCRS supplement context.

A soothing cream and a nutritional supplement serve different purposes. Ingredient familiarity, an antioxidant mechanism or the word “natural” does not demonstrate that a product treats rectal bleeding safely. Confirm the diagnosis and intended symptom target before buying repeated courses.

What works and what does not

Use outcomes that matter: less bleeding, more comfortable bowel movements, less prolapse or difficulty cleaning, and fewer disrupted activities. A cream making the area feel less itchy is useful symptom relief, but does not establish that the cause of bleeding has resolved.

Hydrocortisone-containing products can reduce pain and itching but do not cure piles. Products differ: some are intended only for external application, while other forms have different directions. Choose the appropriate formulation with professional advice. NHS hydrocortisone role.

Avoid the urge to keep applying a steroid cream indefinitely. Persistent symptoms call for reassessment and a bowel-habit plan, not merely a stronger or longer course of the same product.

Take time to discuss procedural trade-offs. A technique that offers a shorter initial recovery may differ in recurrence or suitability for external disease. ASCRS does not recommend stapled haemorrhoidopexy routinely as a first surgical choice. This guide does not rank device brands. ASCRS procedure-selection context.

Symptoms can recur after treatment. Keep the underlying bowel problems in the follow-up discussion and report renewed bleeding rather than assume that a previous diagnosis explains it forever. NHS recurrence context.

Risks and side effects

Obtain emergency care for nonstop bleeding, a large amount of blood or large clots, or severe pain. Do not wait for another cream to work. NHS emergency symptoms.

Fever or shivering with illness, pus or new painful swelling requires urgent review. Black or dark red stool and bloody diarrhoea also need urgent assessment; these are not adequately explained by a routine self-diagnosis of piles. NHS bleeding triage; piles urgent signs.

Prolonged topical hydrocortisone can thin skin and aggravate infection. Seek advice about increasing inflammation or other adverse effects, and use emergency care for a serious allergic reaction. NHS steroid safety.

After a procedure, obtain prompt help for heavy bleeding, fever with severe anal pain or difficulty urinating. These can indicate significant complications rather than ordinary recovery discomfort. Follow the surgeon’s discharge instructions and emergency contact plan. ASCRS post-procedure safety.

Important interactions

Disclose anticoagulants and antiplatelet medicines before a procedure. The team needs to balance bleeding and clotting risks and coordinate any change with the prescriber. Do not stop these medicines independently in order to arrange banding. ASCRS procedural medication review.

NHS guidance advises against ibuprofen when piles are bleeding and notes that codeine can worsen constipation. A pharmacist can check pain relief against the person’s other medicines and actual symptoms. NHS analgesic cautions.

Ispaghula can affect absorption of medicines and supplements. Ask the pharmacist to plan timing, especially with medicines such as lithium, digoxin, diabetes treatment or other prescribed therapy. Do not stack different laxatives unless advised. NHS fibre interactions.

Review every ingredient in a combination cream. An allergy to a local anaesthetic, an existing skin infection or a medicine causing constipation can change suitability. NHS cream suitability.

Who needs special assessment

Bleeding in a child needs clinical assessment, and adult products should not be applied as a child’s treatment plan. Some hydrocortisone products have age restrictions or require a prescription for younger patients. NHS child bleeding advice; medicine age limits.

Pregnancy commonly contributes to piles, but new bleeding or severe pain still deserves evaluation. A midwife, pharmacist or clinician can help select bowel-habit measures and suitable symptom relief rather than assume every pregnancy product is interchangeable.

People with previous bowel disease, a significant family history, unexplained weight loss or continuing changes in bowel habit need a discussion about further assessment. A haemorrhoid diagnosis does not replace appropriate colorectal screening or investigation of new symptoms.

Clinician-led treatment and use

Record the bleeding pattern, pain timing, whether tissue protrudes, stool consistency and previous products used. Describe how symptoms affect toileting, cleaning and daily life. Bring a complete medication list and mention any prior bowel investigations.

Ask which findings confirm haemorrhoids, whether another cause of bleeding needs investigation and which symptom the treatment aims to improve. For a procedure, confirm how recovery will be managed, when normal activities are expected and which complications require immediate contact.

Arrange reassessment if symptoms persist or recur. This guide supplies no individualized fibre amount, fluid target, laxative dose, cream regimen or procedural instructions. Use the actual product leaflet and the clinician’s plan, with a pharmacist’s help when directions are unclear.

Animal and in-vitro evidence

Changes in blood-vessel tone, inflammation or antioxidant markers in laboratory models do not establish reliable symptom relief or safe treatment of rectal bleeding in people. These findings do not support an independent herbal or flavonoid efficacy recommendation here.

Funding and source roles

The older NIDDK series has no named outside expert in its main acknowledgment area; page-level financing and supporting trial finances remain incompletely disclosed. NHS guidance provides current clinical/safety context. ASCRS declares no funding or related competing interests for the 2024 guideline, while separate society reporting documents corporate meeting support. Internal guideline resources and supporting-trial provenance remain unclassified. Clinical guidance is not an automatic independence certificate for supplements or devices.

Frequently asked questions

Are haemorrhoids and piles different? No. They are different names for the same condition.

Is painless bright red bleeding definitely piles? No. Arrange assessment; several conditions can cause it. NHS bleeding assessment.

Does hydrocortisone cure piles? It may relieve pain and itching but is not a cure. NHS treatment role.

Can I band a haemorrhoid myself? No. Banding is a clinician-performed procedure. NIDDK explicit precaution.

Sources and funding notes

NIDDK material is dated October 2016 and was cross-checked against NHS April 2026 piles guidance and the accessible original ASCRS 2024 guideline, DOI 10.1097/DCR.0000000000003276. The old ASCRS PDF link returned 404; its current society-hosted text was read fully, including financial statements. Indexed original annual reporting documents society corporate meeting support; full annual PDF access exceeded tool size, leaving total income/allocation gaps. NHS rectal-bleeding education is dated April 2023 and past its scheduled April 2026 review, so current piles triage was also checked. NHS hydrocortisone pages date to December 2023 and ispaghula pages to January 2026. No corporate supplement/device efficacy result establishes an independent verdict.

1. NIDDK: haemorrhoid definition — Internal/external disease, complications and anatomy; October 2016.
2. NIDDK: symptoms and causes — Bleeding, pain and differential diagnosis; October 2016.
3. NIDDK: diagnosis — Examination, anoscopy and selective other testing; October 2016.
4. NIDDK: treatment — Bowel-habit care and clinician-only procedures; October 2016.
5. NIDDK: diet and nutrition — Fibre-rich foods and individually suitable hydration; older 2016 page with updated reference links.
6. NHS: piles — Current care, analgesic cautions and urgent/emergency symptoms; April 2026.
7. NHS: rectal bleeding — Differential diagnosis and bleeding triage; April 2023, review due April 2026.
8. NHS: hydrocortisone role — Symptom relief rather than cure; external-use/formulation distinctions; December 2023.
9. NHS: hydrocortisone adverse effects — Skin thinning, infection aggravation and allergy; December 2023.
10. NHS: hydrocortisone suitability — Age, infection and allergy cautions; December 2023.
11. NHS: ispaghula suitability — Swallowing/obstruction cautions and specific patient review; January 2026.
12. NHS: ispaghula interactions — Medicine absorption and pharmacist-managed scheduling; January 2026.
13. ASCRS 2024 haemorrhoid guideline — Current care context, phlebotonic limits, procedure safety; no independent commercial efficacy ranking.
14. ASCRS: expanded haemorrhoid patient information — Normal tissue, prolapse grades, external thrombosis and procedural/recovery context.

Educational information reviewed 4 October 2026. This guide supports an informed clinical discussion; it does not diagnose an individual or provide a personal treatment regimen.